Viagra, anti-cancer drug combo shrinks tumors in vivo
September 28th, 2010 - 3:16 pm ICT by ANIWashington, Sep 28 (ANI): Viagra when combined with doxorubicin, a powerful anti-cancer drug, enhances its anti-tumour efficacy in prostate cancer and also lessens the damage to the heart, a new study has suggested.
For more than four decades, the chemotherapeutic agent doxorubicin has been used to treat a number of human cancers, including that of the prostate.
Virginia Commonwealth University School of Medicine and VCU Massey Cancer Center researchers using a variety of powerful in vitro and in vivo approaches, have shown that a combination of Viagra, generically known as sildenafil, and doxorubcin significantly enhances the generation of reactive oxygen species that trigger cell death, or apoptosis, in prostate cancer cells.
They also observed that the combination did not harm the normal, healthy prostate epithelial cells.
“We believe sildenafil could be an excellent candidate for incorporation into cancer treatment protocols - with the potential of enhancing the anti-tumor efficacy, while protecting the heart against both short term and long term damage from doxorubicin,” said principal investigator Rakesh C. Kukreja.
Kukreja’s laboratory is one of the first to explore the area of preconditioning. This preconditioning effect was modelled in his lab by “pretreating” mice with doses of sildenafil, which also increases therapeutic levels of nitric oxide in the heart.
The study was published online in the journal Proceedings of the National Academy of Sciences. (ANI)
- Genes linked to Chemoresistance identified - Jul 21, 2009
- Protein that makes tumor cells in breast cancer resistant to treatments - Dec 15, 2010
- Erectile dysfunction drug could enhance delivery of herceptin to brain tumours - May 08, 2010
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- Antibiotic used in meat, dairy industry slows prostate cancer growth - Dec 21, 2010
- Products to enhance men's sexual performance recalled in NZ - Sep 24, 2010
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Compound boosts cancer-killing properties of agent in trials - Jun 10, 2010
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- New approach could reverse liver failure - Aug 06, 2012
- Cancer anti-depressant can also help fight the disease better - Dec 19, 2008
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Beehive extract may arrest prostate cancer - May 06, 2012
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
Tags: cancer drug, cancer treatment, center researchers, chemotherapeutic agent, doxorubicin, human cancers, journal proceedings, kukreja, massey cancer center, more than four decades, national academy of sciences, oxygen species, proceedings of the national academy of sciences, prostate cancer, prostate cancer cells, therapeutic levels, treatment protocols, virginia commonwealth university, virginia commonwealth university school of medicine, vivo approaches